Cell based approaches for myocardial regeneration and artificial myocardium

Jorge Genovese, Miguel Cortes-Morichetti, Emmanuel Chachques, Giacomo Frati, Amit Patel, Juan C. Chachques

Research output: Contribution to journalArticle

Abstract

Ischemic myocardial disease, the main cause of heart failure, is a major public health and economic problem. Given the aging population, heart failure is becoming an increasing clinical issue and a substantial financial burden. Thus, research in heart failure is of relevant interest and importance, involving specialties such as cellular and molecular biology, tissue engineering, genetics, biophysics and electrophysiology. Stem cell-based regenerative therapy is undergoing experimental and clinical trials in order to limit the consequences of decreased contractile function and compliance of damaged ventricles following myocardial infarction or in patients presenting non-ischemic dilated cardiomyopathies. This biological approach is particularly attractive due to the potential for myocardial regeneration with a variety of myogenic and angiogenic cell types. The development of a bio-artificial myocardium using biological or synthetic matrix is a new challenge.

Original languageEnglish
Pages (from-to)121-127
Number of pages7
JournalCurrent Stem Cell Research and Therapy
Volume2
Issue number2
DOIs
Publication statusPublished - May 2007

Fingerprint

Regeneration
Myocardium
Heart Failure
Biophysics
Electrophysiology
Dilated Cardiomyopathy
Tissue Engineering
Cardiomyopathies
Compliance
Cell Biology
Molecular Biology
Stem Cells
Public Health
Myocardial Infarction
Economics
Clinical Trials
Research
Population
Therapeutics

Keywords

  • Artificial myocardium
  • Cardiomyopathy
  • Cellular cardiomyoplasty
  • Heart failure
  • Ischemic heart disease
  • Stem cell transplantation
  • Tissue engineering

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Cell based approaches for myocardial regeneration and artificial myocardium. / Genovese, Jorge; Cortes-Morichetti, Miguel; Chachques, Emmanuel; Frati, Giacomo; Patel, Amit; Chachques, Juan C.

In: Current Stem Cell Research and Therapy, Vol. 2, No. 2, 05.2007, p. 121-127.

Research output: Contribution to journalArticle

Genovese, J, Cortes-Morichetti, M, Chachques, E, Frati, G, Patel, A & Chachques, JC 2007, 'Cell based approaches for myocardial regeneration and artificial myocardium', Current Stem Cell Research and Therapy, vol. 2, no. 2, pp. 121-127. https://doi.org/10.2174/157488807780599239
Genovese, Jorge ; Cortes-Morichetti, Miguel ; Chachques, Emmanuel ; Frati, Giacomo ; Patel, Amit ; Chachques, Juan C. / Cell based approaches for myocardial regeneration and artificial myocardium. In: Current Stem Cell Research and Therapy. 2007 ; Vol. 2, No. 2. pp. 121-127.
@article{6512ae585212447e88366884a87b233d,
title = "Cell based approaches for myocardial regeneration and artificial myocardium",
abstract = "Ischemic myocardial disease, the main cause of heart failure, is a major public health and economic problem. Given the aging population, heart failure is becoming an increasing clinical issue and a substantial financial burden. Thus, research in heart failure is of relevant interest and importance, involving specialties such as cellular and molecular biology, tissue engineering, genetics, biophysics and electrophysiology. Stem cell-based regenerative therapy is undergoing experimental and clinical trials in order to limit the consequences of decreased contractile function and compliance of damaged ventricles following myocardial infarction or in patients presenting non-ischemic dilated cardiomyopathies. This biological approach is particularly attractive due to the potential for myocardial regeneration with a variety of myogenic and angiogenic cell types. The development of a bio-artificial myocardium using biological or synthetic matrix is a new challenge.",
keywords = "Artificial myocardium, Cardiomyopathy, Cellular cardiomyoplasty, Heart failure, Ischemic heart disease, Stem cell transplantation, Tissue engineering",
author = "Jorge Genovese and Miguel Cortes-Morichetti and Emmanuel Chachques and Giacomo Frati and Amit Patel and Chachques, {Juan C.}",
year = "2007",
month = "5",
doi = "10.2174/157488807780599239",
language = "English",
volume = "2",
pages = "121--127",
journal = "Current Stem Cell Research and Therapy",
issn = "1574-888X",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Cell based approaches for myocardial regeneration and artificial myocardium

AU - Genovese, Jorge

AU - Cortes-Morichetti, Miguel

AU - Chachques, Emmanuel

AU - Frati, Giacomo

AU - Patel, Amit

AU - Chachques, Juan C.

PY - 2007/5

Y1 - 2007/5

N2 - Ischemic myocardial disease, the main cause of heart failure, is a major public health and economic problem. Given the aging population, heart failure is becoming an increasing clinical issue and a substantial financial burden. Thus, research in heart failure is of relevant interest and importance, involving specialties such as cellular and molecular biology, tissue engineering, genetics, biophysics and electrophysiology. Stem cell-based regenerative therapy is undergoing experimental and clinical trials in order to limit the consequences of decreased contractile function and compliance of damaged ventricles following myocardial infarction or in patients presenting non-ischemic dilated cardiomyopathies. This biological approach is particularly attractive due to the potential for myocardial regeneration with a variety of myogenic and angiogenic cell types. The development of a bio-artificial myocardium using biological or synthetic matrix is a new challenge.

AB - Ischemic myocardial disease, the main cause of heart failure, is a major public health and economic problem. Given the aging population, heart failure is becoming an increasing clinical issue and a substantial financial burden. Thus, research in heart failure is of relevant interest and importance, involving specialties such as cellular and molecular biology, tissue engineering, genetics, biophysics and electrophysiology. Stem cell-based regenerative therapy is undergoing experimental and clinical trials in order to limit the consequences of decreased contractile function and compliance of damaged ventricles following myocardial infarction or in patients presenting non-ischemic dilated cardiomyopathies. This biological approach is particularly attractive due to the potential for myocardial regeneration with a variety of myogenic and angiogenic cell types. The development of a bio-artificial myocardium using biological or synthetic matrix is a new challenge.

KW - Artificial myocardium

KW - Cardiomyopathy

KW - Cellular cardiomyoplasty

KW - Heart failure

KW - Ischemic heart disease

KW - Stem cell transplantation

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=34249342307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249342307&partnerID=8YFLogxK

U2 - 10.2174/157488807780599239

DO - 10.2174/157488807780599239

M3 - Article

C2 - 18220897

AN - SCOPUS:34249342307

VL - 2

SP - 121

EP - 127

JO - Current Stem Cell Research and Therapy

JF - Current Stem Cell Research and Therapy

SN - 1574-888X

IS - 2

ER -